170 related articles for article (PubMed ID: 35726194)
61. Graves' disease coexisted with resistance to thyroid hormone: a case report.
Akahori H; Usuda R
J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
[TBL] [Abstract][Full Text] [Related]
62. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
[TBL] [Abstract][Full Text] [Related]
63. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
64. [Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study].
Li QM; Wei JP; Li M; Meng SH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1119-24. PubMed ID: 26591370
[TBL] [Abstract][Full Text] [Related]
65. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A
J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
[TBL] [Abstract][Full Text] [Related]
66. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
[TBL] [Abstract][Full Text] [Related]
67. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
Druetta L; Bornet H; Sassolas G; Rousset B
Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
[TBL] [Abstract][Full Text] [Related]
68. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
[TBL] [Abstract][Full Text] [Related]
69. Use of Lithium in Hyperthyroidism Secondary to Graves' Disease: A Case Report.
Sharma PP
Am J Case Rep; 2022 Apr; 23():e935789. PubMed ID: 35477705
[TBL] [Abstract][Full Text] [Related]
70. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
71. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?
Tigas S; Idiculla J; Beckett G; Toft A
Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857
[TBL] [Abstract][Full Text] [Related]
72. Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism.
Yunta PJ; Ponce JL; Prieto M; López-Aznar D; Sancho-Fornos S
Ann Endocrinol (Paris); 2001 Jun; 62(3):226-9. PubMed ID: 11458174
[TBL] [Abstract][Full Text] [Related]
73. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
[TBL] [Abstract][Full Text] [Related]
74. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
75. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
Gershengorn MC; Weintraub BD
J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
[TBL] [Abstract][Full Text] [Related]
76. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
77. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review.
Menon LP; Naqvi S; Maradana J; Edem D
Cureus; 2024 Jan; 16(1):e52260. PubMed ID: 38352081
[TBL] [Abstract][Full Text] [Related]
78. Graves' disease and recurrence in ectopic thyroid tissue after total thyroidectomy.
Cunha C; Ferrinho C; Saraiva C; Duarte JS
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34315743
[TBL] [Abstract][Full Text] [Related]
79. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
80. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
